Method for treating an autoimmune disease using a soluble CTLA4 molecule and a DMARD or NSAID
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Jul 24, 2012
Grant Date -
Jul 1, 2010
app pub date -
Mar 9, 2010
filing date -
Jul 3, 2000
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
The present invention relates to compositions and methods for treating immune system diseases such as rheumatic disease, by administering to a subject soluble CTLA4 molecules that block endogenous B7 molecules from binding their ligands, alone, or in conjunction with other agents including Disease Modifying Anti-Rheumatic Drugs (DMARDs).
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully